Correlation Between Veracyte and Adaptive Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Veracyte and Adaptive Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Adaptive Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Veracyte and Adaptive Biotechnologies Corp, you can compare the effects of market volatilities on Veracyte and Adaptive Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Adaptive Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Adaptive Biotechnologies.

Diversification Opportunities for Veracyte and Adaptive Biotechnologies

0.87

Correlation Coefficient

Veracyte  Adaptive Biotechnologies

Very poor diversification

The 3 months correlation between Veracyte and Adaptive is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Adaptive Biotechnologies Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adaptive Biotechnologies and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Adaptive Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adaptive Biotechnologies has no effect on the direction of Veracyte i.e., Veracyte and Adaptive Biotechnologies go up and down completely randomly.

Pair Corralation between Veracyte and Adaptive Biotechnologies

Given the investment horizon of 90 days Veracyte is expected to generate 0.34 times more return on investment than Adaptive Biotechnologies. However, Veracyte is 2.93 times less risky than Adaptive Biotechnologies. It trades about -0.27 of its potential returns per unit of risk. Adaptive Biotechnologies Corp is currently generating about -0.19 per unit of risk. If you would invest  2,167  in Veracyte on January 19, 2024 and sell it today you would lose (281.00) from holding Veracyte or give up 12.97% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Veracyte  vs.  Adaptive Biotechnologies Corp

Veracyte

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Veracyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in May 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Adaptive Biotechnologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Adaptive Biotechnologies Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in May 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Veracyte and Adaptive Biotechnologies

The main advantage of trading using opposite Veracyte and Adaptive Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Adaptive Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will offset losses from the drop in Adaptive Biotechnologies' long position.

The idea behind Veracyte and Adaptive Biotechnologies Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.